Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RSV
Pharma
Moderna targets more cost cuts amid uncertainty under RFK Jr.
Moderna is extending its cost savings program into 2027 as the entire vaccine market faces regulatory uncertainties under the Trump administration.
Angus Liu
May 1, 2025 11:13am
ACIP broadens guidance for RSV vaccines from GSK, Pfizer
Apr 17, 2025 11:04am
GSK, Pfizer end RSV patent feud amid vaccine market uncertainty
Apr 4, 2025 10:55am
Moderna takes $238M contract manufacturing cancellation charge
Feb 14, 2025 11:05am
JPM25: Moderna slashes costs, guidance amid poor vaccine sales
Jan 13, 2025 11:31am
FDA requires Pfizer, GSK to add new warning label on RSV shots
Jan 8, 2025 11:57am
